AI Drug Discovery Unicorn Insilico Medicine Jumps In Hong ...
18 hours ago · After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma companies,” says founder Alex Zhavoronkov.
Insilico Medicine Lists on Hong Kong Stock Exchange, Showing ...
1 day ago · Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO Provided by PR Newswire Dec 30, …
Insilico debuts on HK Stock Exchange, locking in more than $290m
10 hours ago · Insilico Medicine IPO signals that AI‑native drug discovery is moving from promise to public markets with a central longevity narrative. Insilico Medicine (3696.HK) has …
Global AI drug firm Insilico raises $293m in Hong Kong IPO
1 day ago · Insilico Medicine Cayman TopCo, an AI-focused drug discovery firm with operations in the US, China, Canada, and the Middle East, raised US$293 million in its Hong Kong IPO and …
Insilico Medicine, despite a $19.22B loss, raised $293M in ...
1 day ago · Insilico Medicine, despite a $19.22B loss, raised $293M in Hong Kong’s largest biotech IPO to expand AI-driven drug discovery globally. Insilico Medicine, a pesar de una …
Insilico Surges After Hong Kong IPO Amid AI Drugmaking ...
1 day ago · Insilico Surges After Hong Kong IPO Amid AI Drugmaking Optimism Artificial Intelligence drug discovery startup Insilico Medicine Cayman TopCo jumped 25% in its Hong …
Bloomberg.com
1 day ago · https://www.bloomberg.com/news/articles/2025-12-30/ai-drug-firm-insilico-debuts-in-hong-kong-after-293-million-ipo